[Proper oral health can protect from developing gingival hyperplasia induced by calcium channel blockers]

Ágnes Bán1, Erika Pintér2, József Kun2

  • 1Klinikai Központ, Fogászati és Szájsebészeti Klinika, Parodontológiai Osztály, Pécsi Tudományegyetem, Fogorvos-tudományi Kar Pécs.

Orvosi Hetilap
|July 17, 2018
PubMed

Insights

Calcium channel blockers can cause gingival hyperplasia, a gum overgrowth condition linked to poor oral hygiene and plaque. Maintaining good dental care can prevent this side effect, even during hypertension treatment.

Area of Science:

  • Cardiology
  • Periodontology
  • Pharmacology

Background:

  • Cardiovascular diseases, including hypertension, are prevalent, affecting 40% of Hungarian adults.
  • Calcium channel blockers (CCBs) are common hypertension treatments, with gingival hyperplasia as a known side effect.
  • Gingival hyperplasia induced by CCBs is influenced by dental status and plaque accumulation.

Purpose of the Study:

  • To highlight the correlation between CCB-induced gingival hyperplasia, dental health, and plaque levels.
  • To emphasize the impact of gingival hyperplasia on oral hygiene and its potential to exacerbate cardiovascular risks.
  • To advocate for improved interdisciplinary collaboration between internists and dentists for patient oral health.

Main Methods:

  • Observational analysis of patients undergoing calcium channel blocker therapy.
  • Assessment of dental status and plaque quantity in relation to gingival hyperplasia.
  • Literature review on the mechanisms of CCB-induced gingival overgrowth.

Main Results:

  • CCB-induced gingival hyperplasia is closely associated with poor dental hygiene and increased plaque.
  • Established gingival hyperplasia complicates oral hygiene, promoting bacterial proliferation and potential cardiovascular disease risk.
  • Effective oral hygiene and professional dental care can maintain healthy gingival states during CCB therapy.

Conclusions:

  • Gingival hyperplasia management requires addressing dental status and plaque control.
  • Preventive oral care is crucial for patients on CCBs to mitigate hyperplasia and associated risks.
  • Enhanced collaboration between physicians and dentists is essential for comprehensive patient care.

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.3K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.5K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.8K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.0K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
550
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.8K